Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Aripiprazole in Major Depressive Disorder (Placebo-Controlled, Double-Blind)
jRCT2080220698Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aripiprazole in major depressive disorder (MDD) (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on jRCT2080220698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220698.